Erik Corcoran
Impact in
-
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
-
- Antifungal resistance and susceptibility
Papers in
-
- Angiogenesis and VEGF in Cancer 3
-
- Antifungal resistance and susceptibility 1
- Co-authors
- James R. Tonra (8 shared papers)Daniel J. Hicklin (4 shared papers)Dhanvanthri S. Deevi (4 shared papers)Huiling Li (2 shared papers)Su Wang (1 shared paper)Francine E. Carrick (1 shared paper)Elizabeth Navarro (2 shared papers)Yan Wu (2 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (3 papers)Clinical Cancer Research (2 papers)Frontiers in Immunology (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)Neoplasia (1 paper)
- Partner nations
- United States
In The Last Decade
Erik Corcoran
12 papers receiving 455 citations
Peers
Comparison fields: 5 of 65
- Oncology 157
- Infectious Diseases 87
- Cancer Research 69
- Molecular Medicine 19
- Small Animals 22
Countries citing papers authored by Erik Corcoran
This map shows the geographic impact of Erik Corcoran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Corcoran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Corcoran more than expected).
Fields of papers citing papers by Erik Corcoran
This network shows the impact of papers produced by Erik Corcoran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Corcoran. The network helps show where Erik Corcoran may publish in the future.
Co-authors
The 25 scholars most cited alongside Erik Corcoran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 127 | |
| 2 | 2006 | 121 | |
| 3 | 2000 | 90 | |
| 4 | 2005 | 53 | |
| 5 | 2009 | 40 | |
| 6 | 2011 | 14 | |
| 7 | 2006 | 13 | |
| 8 | 2007 | 9 | |
| 9 | Prioritization of EGFR/IGF-IR/VEGFR2 combination targeted therapies utilizing cancer models. | 2009 | 8 |
| 10 | 2022 | 4 | |
| 11 | 2006 | 3 | |
| 12 | 2008 | 1 |
About Erik Corcoran
Erik Corcoran is a scholar working on Molecular Biology, Infectious Diseases, Pharmacology, Oncology and Epidemiology, having authored 12 papers that have together received 483 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (3 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Antibiotic Resistance in Bacteria (2 papers), Renal cell carcinoma treatment (1 paper), Acne and Rosacea Treatments and Effects (1 paper), Hair Growth and Disorders (1 paper) and Antifungal resistance and susceptibility (1 paper). The work is most often cited by research in Oncology (157 citations), Infectious Diseases (87 citations), Cancer Research (69 citations), Molecular Medicine (19 citations) and Small Animals (22 citations). Erik Corcoran has collaborated with scholars based in United States. Frequent co-authors include James R. Tonra, Daniel J. Hicklin, Dhanvanthri S. Deevi, Huiling Li, Su Wang, Francine E. Carrick, Elizabeth Navarro, Yan Wu, Dale L. Ludwig and James Huber. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Clinical Cancer Research, Frontiers in Immunology, Bioorganic & Medicinal Chemistry Letters and Neoplasia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.